By Associate Professor Julia Lappin

Journal articles

Darke S; Kaye S; Duflou J; Lappin J, 2019, 'Completed Suicide Among Methamphetamine Users: A National Study', Suicide and Life-Threatening Behavior, 49, pp. 328 - 337, http://dx.doi.org/10.1111/sltb.12442

Teasdale SB; Ward PB; Jarman R; Wade T; Rossimel E; Curtis J; Lappin J; Watkins A; Samaras K, 2018, 'Is Obesity in Young People With Psychosis a Foregone Conclusion? Markedly Excessive Energy Intake Is Evident Soon After Antipsychotic Initiation', FRONTIERS IN PSYCHIATRY, 9, http://dx.doi.org/10.3389/fpsyt.2018.00725

Curtis J; Zhang C; McGuigan B; Pavel-Wood E; Morell R; Ward PB; Watkins A; Lappin J, 2018, 'y-QUIT: Smoking Prevalence, Engagement, and Effectiveness of an Individualized Smoking Cessation Intervention in Youth With Severe Mental Illness', Frontiers in Psychiatry, 9, pp. 683, http://dx.doi.org/10.3389/fpsyt.2018.00683

Sara G; Baxter C; Menendez P; Lappin J, 2018, 'Amphetamine availability predicts amphetamine-related mental health admissions: A time series analysis', Australian and New Zealand Journal of Psychiatry, 52, pp. 1050 - 1056, http://dx.doi.org/10.1177/0004867418763538

Su MF; Liu MX; Li JQ; Lappin JM; Li SX; Wu P; Liu ZM; Shi J; Lu L; Bao Y, 2018, 'Epidemiological characteristics and risk factors of methamphetamine-associated psychotic symptoms', Frontiers in Psychiatry, 9, pp. 489, http://dx.doi.org/10.3389/fpsyt.2018.00489

Lappin JM; Ayub MH; Rogers D; Morgan M; Kanyamibwa JY; Shakeshaft A, 2018, 'Routine screening and related interventions significantly improve the effectiveness of emergency department detection and management of alcohol withdrawal syndrome', EMA - Emergency Medicine Australasia, 30, pp. 648 - 653, http://dx.doi.org/10.1111/1742-6723.12959

Boydell KM; Ball J; Curtis J; De Jager A; Kalucy M; Lappin J; Rosenbaum S; Tewson A; Vaughan P; Ward PB; Watkins A, 2018, 'A Novel Landscape for Understanding Physical and Mental Health: Body Mapping Research with Youth Experiencing Psychosis', Art/Research International: A Transdisciplinary Journal, 3, pp. 236 - 261, http://dx.doi.org/10.18432/ari29337

Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J, 2018, 'Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients', Schizophrenia Research, 199, pp. 367 - 373, http://dx.doi.org/10.1016/j.schres.2018.02.035

Darke S; Duflou J; Lappin J; Kaye S, 2018, 'Clinical and Autopsy Characteristics of Fatal Methamphetamine Toxicity in Australia', Journal of Forensic Sciences, 63, pp. 1466 - 1471, http://dx.doi.org/10.1111/1556-4029.13710

Lappin JM; Heslin M; Lomas B; Jones PB; Doody GA; Reininghaus UA; Croudace T; Craig T; Fearon P; Murray RM; Dazzan P; Morgan C, 2018, 'Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study', Schizophrenia Research, 199, pp. 341 - 345, http://dx.doi.org/10.1016/j.schres.2018.03.014

Curtis J; Watkins A; Teasdale S; Lederman O; Kalucy M; Lappin J; Samaras K; Rosenbaum S; Ward PB, 2018, '2-year follow-up: Still keeping the body in mind', Australian and New Zealand Journal of Psychiatry, 52, pp. 602 - 603, http://dx.doi.org/10.1177/0004867417753553

Lappin JM; Darke S; Farrell M, 2018, 'Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications', Drug and Alcohol Dependence, 187, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.032

Ma J; Li XD; Wang TY; Li SX; Meng SQ; Blow FC; Ilgen M; Degenhardt L; Lappin J; Wu P; Shi J; Bao YP; Lu L, 2018, 'Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study', Drug and Alcohol Dependence, 187, pp. 363 - 369, http://dx.doi.org/10.1016/j.drugalcdep.2018.03.023

Darke S; Lappin J; Kaye S; Duflou J, 2018, 'Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study', Journal of Forensic Sciences, 63, pp. 735 - 739, http://dx.doi.org/10.1111/1556-4029.13620

Morgan C; Dazzan P; Lappin J; Heslin M; Doody G; Murray R; Jones PB; Reininghaus U, 2018, '5.2 RETHINKING THE COURSE OF PSYCHOTIC DISORDERS: IDENTIFYING LATENT TRAJECTORIES', Schizophrenia Bulletin, 44, pp. S6 - S6, http://dx.doi.org/10.1093/schbul/sby014.014

Fornells-Ambrojo M; Pocock P; Mintah R; Barker C; Craig T; Lappin JM, 2018, 'Co-morbid personality disorder in early intervention psychosis clients is associated with greater key worker emotional involvement', Early Intervention in Psychiatry, 12, pp. 143 - 152, http://dx.doi.org/10.1111/eip.12286

Poon AWC; Curtis J; Ward P; Loneragan C; Lappin J, 2018, 'Physical and psychological health of carers of young people with first episode psychosis', Australasian Psychiatry, 26, pp. 184 - 188, http://dx.doi.org/10.1177/1039856217748250

Lappin JM; Darke S; Duflou J; Kaye S; Farrell M, 2018, 'Fatal stroke in pregnancy and the puerperium: Case series', Stroke, 49, pp. 3050 - 3053, http://dx.doi.org/10.1161/STROKEAHA.118.023274

Sara G; Lappin J; Dobbins T; Dunlop AJ; Degenhardt L, 2017, 'Escalating patterns of emergency health care prior to first admission with amphetamine psychosis: A window of opportunity?', Drug and Alcohol Dependence, 180, pp. 171 - 177, http://dx.doi.org/10.1016/j.drugalcdep.2017.08.009

Lappin JM; Darke S; Farrell M, 2017, 'Stroke and methamphetamine use in young adults: a review', Journal of Neurology Neuropsychiatry and Psychiatry, 88, pp. 1079 - 1091, http://dx.doi.org/10.1136/jnnp-2017-316071

Demjaha A; Lappin JM; Stahl D; Patel MX; MacCabe JH; Howes OD; Heslin M; Reininghaus UA; Donoghue K; Lomas B; Charalambides M; Onyejiaka A; Fearon P; Jones P; Doody G; Morgan C; Dazzan P; Murray RM, 2017, 'Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors', Psychological medicine, 47, pp. 1981 - 1989, http://dx.doi.org/10.1017/S0033291717000435

Morgan C; Fearon P; Lappin J; Heslin M; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Doody GA; Dazzan P, 2017, 'Ethnicity and long-term course and outcome of psychotic disorders in a UK sample: The ÆsOP-10 study', British Journal of Psychiatry, 211, pp. 88 - 94, http://dx.doi.org/10.1192/bjp.bp.116.193342

Sara G; Lappin J, 2017, 'Childhood trauma: psychiatry's greatest public health challenge?', The Lancet Public Health, 2, pp. e300 - e301, http://dx.doi.org/10.1016/S2468-2667(17)30104-4

Lappin JM; Sara GE; Farrell M, 2017, 'Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention', Addiction, 112, pp. 927 - 928, http://dx.doi.org/10.1111/add.13663

Al Fayez H; Lappin J; Murray R; Boydell J, 2017, 'Duration of untreated psychosis and pathway to care in Riyadh, Saudi Arabia', Early Intervention in Psychiatry, 11, pp. 47 - 56, http://dx.doi.org/10.1111/eip.12214

Nieuwenhuis M; Schnack HG; van Haren NE; Kahn RS; Lappin J; Dazzan P; Morgan C; Reinders AA; Gutierrez-Tordesillas D; Roiz-Santiañez R; Crespo-Facorro B; Schaufelberger MS; Rosa PG; Zanetti MV; Busatto GF; McGorry PD; Velakoulis D; Pantelis C; Wood SJ; Mourao-Miranda J, 2017, 'Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients', NeuroImage, 145, pp. 246 - 253, http://dx.doi.org/10.1016/j.neuroimage.2016.07.027

Jensen C; Curtis J; Lappin J, 2016, 'Acute tranquilisation in young people with first-episode psychosis: Let's start low, go slow', Australian and New Zealand Journal of Psychiatry, 50, pp. 1204 - 1205, http://dx.doi.org/10.1177/0004867416659364

Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018

Lappin JM; Heslin M; Jones PB; Doody GA; Reininghaus UA; Demjaha A; Croudace T; Jamieson-Craig T; Donoghue K; Lomas B; Fearon P; Murray RM; Dazzan P; Morgan C, 2016, 'Outcomes following first-episode psychosis - Why we should intervene early in all ages, not only in youth', Australian and New Zealand Journal of Psychiatry, 50, pp. 1055 - 1063, http://dx.doi.org/10.1177/0004867416673454

Egerton A; Valmaggia LR; Howes OD; Day F; Chaddock CA; Allen P; Winton-Brown TT; Bloomfield MAP; Bhattacharyya S; Chilcott J; Lappin JM; Murray RM; McGuire P, 2016, 'Adversity in childhood linked to elevated striatal dopamine function in adulthood', Schizophrenia Research, 176, pp. 171 - 176, http://dx.doi.org/10.1016/j.schres.2016.06.005

Boydell K; Curtis J; de Jager A; Kalucy M; Khut G; Lappin J; Rosenbaum S; Tewson A; Ward P; Watkins A, 2016, 'Keeping the Body in Mind over Time: Mapping Experiences of Young People with Psychosis', EARLY INTERVENTION IN PSYCHIATRY, 10, pp. 107 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385582800317&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Heslin M; Lappin JM; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Dazzan P; Craig TJ; Morgan C, 2016, 'Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients', Schizophrenia Research, 176, pp. 417 - 422, http://dx.doi.org/10.1016/j.schres.2016.04.049

Kay-Lambkin FJ; Thornton L; Lappin JM; Hanstock T; Sylvia L; Jacka F; Baker AL; Berk M; Mitchell PB; Callister R; Rogers N; Webster S; Dennis S; Oldmeadow C; MacKinnon A; Doran C; Turner A; Hunt S, 2016, 'Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder', Systematic Reviews, 5, pp. 106, http://dx.doi.org/10.1186/s13643-016-0282-9

Heslin M; Desai R; Lappin JM; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Dazzan P; Fisher HL; Demjaha A; Craig T; Morgan C, 2016, 'Biological and psychosocial risk factors for psychotic major depression', Social Psychiatry and Psychiatric Epidemiology, 51, pp. 233 - 245, http://dx.doi.org/10.1007/s00127-015-1131-1

Heslin M; Desai R; Lappin JM; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Dazzan P; Fisher HL; Demjaha A; Craig T; Morgan C, 2015, 'Biological and psychosocial risk factors for psychotic major depression', Social Psychiatry and Psychiatric Epidemiology, 51, pp. 233 - 245, http://dx.doi.org/10.1007/s00127-015-1131-1

Heslin M; Lomas B; Lappin JM; Donoghue K; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Dazzan P; Morgan C; Doody GA, 2015, 'Diagnostic change 10 years after a first episode of psychosis', Psychological Medicine, 45, pp. 2757 - 2769, http://dx.doi.org/10.1017/S0033291715000720

Revier CJ; Reininghaus U; Dutta R; Fearon P; Murray RM; Doody GA; Croudace T; Dazzan P; Heslin M; Onyejiaka A; Kravariti E; Lappin J; Lomas B; Kirkbride JB; Donoghue K; Morgan C; Jones PB, 2015, 'Ten-year outcomes of first-episode psychoses in the MRC ÆsOP-10 study', Journal of Nervous and Mental Disease, 203, pp. 379 - 386, http://dx.doi.org/10.1097/NMD.0000000000000295

Reininghaus U; Dutta R; Dazzan P; Doody GA; Fearon P; Lappin J; Heslin M; Onyejiaka A; Donoghue K; Lomas B; Kirkbride JB; Murray RM; Croudace T; Morgan C; Jones PB, 2015, 'Mortality in schizophrenia and other psychoses: A 10-year follow-up of the ÆsOP first-episode cohort', Schizophrenia Bulletin, 41, pp. 664 - 673, http://dx.doi.org/10.1093/schbul/sbu138

Shaikh M; Dutt A; Broome MR; Vozmediano AG; Ranlund S; Diez A; Caseiro O; Lappin J; Amankwa S; Carletti F; Fusar-Poli P; Walshe M; Hall MH; Howes O; Ellett L; Murray RM; McGuire P; Valmaggia L; Bramon E, 2015, 'Sensory gating deficits in the attenuated psychosis syndrome', Schizophrenia Research, 161, pp. 277 - 282, http://dx.doi.org/10.1016/j.schres.2014.12.021

Morgan C; Lappin J; Heslin M; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Dazzan P, 2014, 'Erratum: Reappraising the long-term course and outcome of psychotic disorders: The AESOP-10 study (Psychological Medicine (2014) DOI: :10.1017/S0033291714000282)', Psychological Medicine, 44, pp. 2727, http://dx.doi.org/10.1017/S0033291714000890

Morgan C; Lappin J; Heslin M; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Dazzan P, 2014, 'Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study', Psychological medicine, 44, pp. 2713 - 2726, http://dx.doi.org/10.1017/S0033291714000282

Lappin JM; Morgan C; Chalavi S; Morgan KD; Reinders AATS; Fearon P; Heslin M; Zanelli J; Jones PB; Murray RM; Dazzan P, 2014, 'Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes', Psychological Medicine, 44, pp. 1279 - 1291, http://dx.doi.org/10.1017/S0033291713001712

Demjaha A; Lappin J; Patel MX; MacCabe JH; Morgan K; Reininghaus U; Howes O; Jones PB; Murray RM; Morgan C; Dazzan P, 2014, '5:15 PM IS TREATMENT RESISTANT SCHIZOPHRENIA A “TYPE” OR A “STAGE” OF PSYCHOTIC ILLNESS?', Schizophrenia Research, 153, pp. S64 - S64, http://dx.doi.org/10.1016/s0920-9964(14)70205-1

Morgan C; Lappin J; Heslin M; Croudace T; Doody G; Donoghue K; Jones PB; Murray RM; Fearon P; Dazzan P, 2014, 'Poster #T165 ETHNICITY, SOCIAL DISADVANTAGE AND THE LONG-TERM COURSE AND OUTCOME OF PSYCHOSIS', Schizophrenia Research, 153, pp. S348 - S348, http://dx.doi.org/10.1016/s0920-9964(14)70982-x

Kravariti E; Russo M; Vassos E; Morgan K; Fearon P; Zanelli JW; Demjaha A; Lappin JM; Tsakanikos E; Dazzan P; Morgan C; Doody GA; Harrison G; Jones PB; Murray RM; Reichenberg A, 2012, 'Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis', Schizophrenia Research, 140, pp. 221 - 231, http://dx.doi.org/10.1016/j.schres.2012.06.008

Mourao-Miranda J; Reinders AATS; Rocha-Rego V; Lappin J; Rondina J; Morgan C; Morgan KD; Fearon P; Jones PB; Doody GA; Murray RM; Kapur S; Dazzan P, 2012, 'Individualized prediction of illness course at the first psychotic episode: A support vector machine MRI study', Psychological Medicine, 42, pp. 1037 - 1047, http://dx.doi.org/10.1017/S0033291711002005

Reeves SJ; Polling C; Stokes PRA; Lappin JM; Shotbolt PP; Mehta MA; Howes OD; Egerton A, 2012, 'Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators', Psychiatry Research - Neuroimaging, 202, pp. 60 - 64, http://dx.doi.org/10.1016/j.pscychresns.2011.09.011

Stokes PRA; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR, 2012, 'History of cannabis use is not associated with alterations in striatal dopamine D 2/D 3 receptor availability', Journal of Psychopharmacology, 26, pp. 144 - 149, http://dx.doi.org/10.1177/0269881111414090

Shaikh M; Valmaggia L; Broome MR; Dutt A; Lappin J; Day F; Woolley J; Tabraham P; Walshe M; Johns L; Fusar-Poli P; Howes O; Murray RM; McGuire P; Bramon E, 2012, 'Reduced mismatch negativity predates the onset of psychosis', Schizophrenia Research, 134, pp. 42 - 48, http://dx.doi.org/10.1016/j.schres.2011.09.022

Fisher HL; Craig TK; Fearon P; Morgan K; Dazzan P; Lappin J; Hutchinson G; Doody GA; Jones PB; McGuffin P; Murray RM; Leff J; Morgan C, 2011, 'Reliability and comparability of psychosis patients' retrospective reports of childhood abuse', Schizophrenia Bulletin, 37, pp. 546 - 553, http://dx.doi.org/10.1093/schbul/sbp103

Back to profile page